Introduction: A Market Recalibrated
Over the past five years, companies operating within the Physician Services and Multi-Site Healthcare sectors have struggled to address the many challenges that arose during the COVID-19 pandemic, as well as other macro headwinds. Reduced government reimbursement, a white-hot labor market driving up wages for both clinical and non-clinical staff, physician and nurse burnout leading to attrition, a sharp reduction in clinical demand during the early stages of the pandemic, and a subsequent massive surge in elective procedure demand have all combined to challenge even the most well-run physician services organizations.
From an M&A perspective, deal activity accelerated sharply out of pandemic lockdowns and produced record volumes at elevated valuations, supported by historically low interest rates and a healthy dose of market exuberance. As a result, healthcare services M&A activity peaked at over 1,700 deals in 2022 with deal value surpassing $190 billion in 2021. Since then, healthcare services M&A deal volume has declined year-over-year as businesses have struggled to navigate the various headwinds highlighted above, and as business owners struggled to adjust their valuation expectations to a new normal. The ‘higher-for-longer’ interest rate environment exposed businesses that were entirely driven by inorganic growth, as financing M&A became significantly more expensive.
Deal activity has now stabilized. According to PwC, healthcare services deal volume held at roughly 1,300 to 1,400 transactions in 2024, well above the pre-COVID baseline of approximately 800 transactions annually. As of June 30, 2026, the effective federal funds rate has stabilized at [3.63]%, a significant decline from the 5.33% peak in 2025, supporting a more robust and consistent M&A environment. More importantly, capital is flowing back to the sector at scale. Bain & Company reported that 2025 healthcare PE deal value exceeded $190 billion, surpassing the prior 2021 peak, with 445 buyouts representing the second-highest annual total on record. In 2026, buyers are showing renewed conviction in the sector, though the operative phrase remains "quality over quantity."
PPM and provider outsourcing models offer steady growth, economic resilience, and notably greater insulation from AI disruption than many other healthcare categories. Investors are focused on organic growth first, hesitant to rely on M&A to drive the top line. Wage inflation and reimbursement pressures have stabilized meaningfully since the pandemic, and while the One Big Beautiful Bill Act (OBBBA) introduced a new set of factors to consider, investors have mostly quantified and priced these new market risks into their underwriting models.
Pillars Driving Market Activity & Deal Success
The Physician Services market is not the same market it was in 2021, and that is a good thing. Underwriting standards have tightened, capital structures have rationalized, and platforms have continued to grow into their valuations.
What has not changed is the fundamental thesis for building scaled provider groups: an aging population, a chronically constrained physician workforce, increased complexity in care delivery (requiring ever-greater investments in technology and systems), and hospital systems operating under structural margin pressure. Absent a fundamental change in the country’s ability to dramatically increase the supply of a well-trained clinical workforce, our health system must continue seeking ways to deliver care more efficiently without sacrificing quality. Any discussion of solutions inevitably starts with the assumption of scale in order to fund and effectuate these new operational strategies.
Defensive Revenue and Demographic Tailwinds
Within specialty provider and PPM platforms, investor interest is notably weighted toward subsectors that offer highly defensive revenue characteristics:
- Clinically Essential: Specialties such as cardiovascular or orthopedic care are attractive because they are heavily insulated by sheer clinical necessity and volume. An aging baby boomer population cannot defer critical treatments, making these specialties resistant to macroeconomic or consumer discretionary spending slowdowns.
- Cash-Pay / Self-Pay: Categories such as XXXX and YYYY are highly attractive given strong commercial pricing power, zero or limited reimbursement risk, and insulation from Medicare/Medicaid policy shifts, even if these businesses are more closely tied to the broader macroeconomic environment.
Capital Markets Support
Public equities sit near all-time highs, interest rates have stabilized, and private capital availability remains deep. According to PitchBook, global private capital funds held $4.63 trillion of dry powder at mid-year 2025. Debt markets have followed suit, with private credit providing flexible structures for sponsor-led platform recaps and add-on M&A. The capital is available—the bar for deployment has simply risen, and private equity investors are increasingly willing to clear it for the right asset.
Integration: An Operational Mandate
Beyond simple consolidation, 2026 is seeing a pivot toward rigorous operational integration. Strategic consolidators have underscored that the next phase of value creation requires migrating disparate acquisitions onto unified administrative and clinical platforms—and building deep institutional competency across three distinct capability layers:
- Practice Management and RCM form the operational foundation. Standardizing workflows, eliminating redundant overhead, and driving EBITDA margin improvement separates a true platform from a simple aggregation story. This is where AI is emerging as a transformative tailwind.
- Clinical Systems provide the proprietary data layer. Unified EHR and decision support tools enable population health management, quality-based contracting, real-world analytics, and evidence-driven data, creating competitive advantages that compound on each other and cannot be replicated through financial engineering.
- Direct-to-Patient Distribution and Clinical Programs represent a strategic prize. Distributors such as Cardinal Health, Cencora, and McKesson are acquiring PPM platforms not solely for clinical scale, but to control the physician-patient relationship as a channel for specialty Rx dispensing. Consolidators who can close the loop from clinical decision to patient doorstep - particularly in high-growth categories like GLP-1s and oncology - transform a physician services platform into a vertically integrated specialty distribution asset.
Ownership of each of these capabilities may not always be required, but the integration competency is non-negotiable. For many consolidators, targeted platform acquisitions will prove the most reliable path to building it.
The Maturity Curve of Related Assets
A deep pipeline of scaled platform assets sits in investors’ backlogs awaiting recapitalization or strategic sale. Appetite for add-on M&A has intensified as platforms execute against growth plans. Critically, valuations are normalizing, narrowing the bid-ask spread that stalled so many processes in the 2023 - 2025 period, resulting in better buyer and seller convergence.
Sector Spotlight: Healthcare Services to Hospitals & Physician Staffing
As hospitals have emerged from the immediate operational crises of COVID-19, they are navigating a new landscape defined by intense and persistent margin pressures. Health systems are currently battling a confluence of systemic headwinds, including reimbursement cuts, reductions in Medicaid coverage, the ongoing administrative and financial impacts of the No Surprises Act, and wage inflation.
In response to these pressures, hospital leadership has been forced to think critically about the services they provide within their four walls. To protect the bottom line and optimize efficiency, health systems have become increasingly open to outsourcing a wide array of functions and service lines. Today, outsourced hospital services businesses offer a variety of solutions, driving sustained growth across department management, pharmacy operations, surgery center management and clinical staffing, among other areas.
Within this broader secular shift toward outsourced services, one of the most compelling structural trends unfolding in real time is the migration of physician labor from a fixed to a variable cost on the hospital P&L. Persistent margin pressure on health systems - driven by labor inflation, payer mix headwinds, and capacity constraints - is forcing a strategic reliance on contracted physician labor in lieu of permanent FTEs. Locum tenens and specialized physician staffing providers are direct beneficiaries.
The numbers tell the story. According to Staffing Industry Analysts, the U.S. locum tenens market reached approximately $9.6 billion in 2025 with steady annual growth projected in the 4–5% range driven by physician shortages, rising patient demand, and a structural shift toward variable labor models. CHG Healthcare's 2025 State of Locum Tenens Report notes that locum tenens is the only temporary healthcare staffing segment to have grown every year since 2021, with roughly 80% of healthcare organizations planning to maintain or increase locum utilization. For investors, the secular and cyclical theses point in the same direction.
Select Representative Transactions
Activity over the past 18 months reflects the themes outlined above: platform recapitalizations at scale, take-privates of public assets, and the continued consolidation across specialty platforms. TripleTree has been at the center of this market movement.
Connect with TripleTree
As deal flow accelerates through the back half of 2026, we expect quality healthcare services assets with clean organic growth stories and defensible reimbursement profiles to command meaningful premiums. TripleTree remains at the epicenter of these transformative transactions - connect with us to discuss how these structural market shifts are driving M&A strategy.
